drugset / Trial / NCT01147081

Safety and Immunogenicity, Inactivated Split Influenza Vaccine, Using the Strain Composition 2010/2011

NCT01147081

Phase 3 Completed 142 enrolled Novartis Vaccines
NaSingle-groupOpen-labelPrevention

Summary

Annual trial for registration influenza vaccine Begrivac with strain composition for season 2010/2011.

Timeline

Start
2010-06
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Begrivac® Vaccine

Indications